15 May 2025 Obesity drugs found to improve emotional wellbeing as well as physical health A major new meta-analysis from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at Kings College London has found that glucagon-like peptide 1 receptor agonists (GLP1- RAs) - a class of medications used to treat obesity and diabetes may also offer benefits for emotional wellbeing in overweight users
In contrast, combining antioxidants with treatments that induce apoptosis through ROS-independent pathways may provide synergistic benefits and improve therapeutic outcomes
Readers are encouraged to verify all details directly with Found Health and their healthcare provider before making decisions
J Cell Mol Med (2011) 15(4):70117.10.1111/j.1582-4934.2010.01237.x 78 TajtiJMajlathZSzokDCsatiAToldiJFulopFet alNovel kynurenic acid analogues in the treatment of migraine and neurodegenerative disorders: preclinical studies and pharmaceutical design
other outcomes were cardiovascular and total death, nonfatal myocardial infarction (MI), nonfatal stroke, hospitalization for heart failure (HHF), and renal outcome
This is not a contradiction so much as a reflection of how complex the nervous system truly is